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Summary 
The goal of this study was to examine the in vivo site 
of autoantibody production in normal and autoim- 
mune-prone mice. B cells were identified in tissue sec- 
tions with IgM- and IgG2a-specific riboprobes that 
readily distinguished resting cells from antibody- 
forming cells (AFC). In normal mice, the few identifi- 
able IgG2a-secreting cells were found in the red pulp. 
By contrast, in Ipr mice exceedingly high numbers of 
lgG2a and autoantibody-producing cells were found 
deep within the T cell-rich periarteriolar lymphoid 
sheaths (PALS). This unusual anatomic location of au- 
toantibody-secreting B cells is unique to Fas dysregu- 
lated strains, since IgG2a-producing cells in ML/+ 
and (SWR x NZB)Fl mice were found predominantly 
in the red pulp or outer PALS, similar to normal mice. 
Furthermore, analysis of spleens from Ipr and non-lpr 
anti-DNA immunoglobulin transgenic mice revealed 
dramatic accumulation of Tg+ cells in the inner PALS 
only in Iprmice. These data suggest that in the absence 
of Fas, autoreactive B cells accumulate in T cell-rich 
zones, and this anatomic feature may contribute to 
autoantibody production. 
Introduction 
The homozygous recessive mutations, Ipr and g/d, have 
recently been mapped to the genes encoding the mem- 
brane proteins Fas and Fas ligand (FasL), respectively 
(Itoh et al., 1991; Watanabe-Fukunaga et al., 1992a; Adachi 
et al., 1993; Takahasi et al., 1994). This receptor-ligand 
combination is involved in the induction of apoptosis 
(Trauth et al., 1989; Yonehara et al., 1989: ltoh et al., 
1991; Watanabe-Fukunaga et al., 1992b; Ju et al., 1995; 
Rothstein et al., 1995). lmmunoregulatory defects re- 
sulting from the inability of lymphocytes to respond to Fasl 
FasL-mediated apoptotic signals lead to an early Onset 
autoimmune syndrome associated with excessive autoan- 
tibody production (Cohen and Eisenberg, 1991). By 10 
weeks of age, serum immunoglobulin G2a (lgG2a) titers 
are at least lo-fold higher in MRUlpr mice than in MRLI+ 
mice, and anti-lgG2a rheumatoid factor (RF) titers are 
commonly lOO-fold higher. With disease progression, se- 
rum lgG2a levels of MRUlpr mice frequently increase to 
20-to 50-fold above control values, while the RF titers can 
increase lO,OOO-fold (Wolfowicz et al., 1988). Monoclonal 
or oligoclonal expansions of RF-producing cells have been 
shown to contribute significantly to the serum RF titers 
(Shlomchik et al., 1987, Wolfowicz et al., 1988). Although 
it is not known what fraction of IgG2a-producing B cells 
is specific for autoantigens, anti-nuclear autoantibodies 
frequently use the lgG2a isotype (Slack et al., 1984; Rubin 
et al., 1986) and anti-DNA and anti-Sm antibodies have 
also been shown to undergo monoclonal or oligoclonal 
expansions(Eisenbergetal., 1982; Shlomchiket al., 1990; 
Bloom et al., 1993). Therefore, it is likely that autoantibod- 
ies of the lgG2a subtype contribute significantly to IgG2a 
serum levels. 
Previous in vivo studies have demonstrated an intrinsic 
defect in Ipr B cells. In various chimeric animal models 
where Ipr B cells were allowed to develop in vivo alongside 
normal B cells, it was found that the vast majority of circu- 
lating IgM and IgG was derived from the Ipr B cells (Perkins 
et al., 1990; Nemazee et al., 1991). In such chimeras, 
normal B cell development and function were presumably 
curtailed by FasL-dependent mechanisms. It was further 
shown that to develop autoantibody production, both the 
T and B cell compartments had to express the /pr defect 
(Sobel et al., 1991). These studies strongly indicated that 
the development of autoantibody production in Ipr mice 
is not simply the result of excessive or abnormal T cell 
help. Subsequent in vitro experiments have shown that 
the Ipr defect directly affects B cell regulation, resulting 
in an inability of B cells (Rothstein et al., 1995) as well 
as T cells (Ju et al., 1995; Brunner et al., 1995, Dhein et 
al., 1995) to undergo Fas-mediated apoptosis. Despite 
these documented effects of the Ipr mutation on B cell 
survival and autoantibody production, conventional anti- 
body responses in prediseased Ipr mice, but not diseased 
animals, appear relatively normal (Creighton et al., 1979; 
Parketal., 1983; Veryet al., 1993) suggestingafunctional 
dichotomy between autoantibody and conventional anti- 
body responses. 
The inability of Ipr B cells to undergo FasL-mediated 
apoptosis has been shown to lead to an apparent break- 
down in peripheral B cell tolerance. Rathmell and Good- 
now (1994) have examined the B cell compartments of 
normal and Ipr mice expressing a combination of anti-hen 
egg lysozyme (HEL) B cell receptor transgenes and endog- 
enous HEL. They found that elimination of HEL-reactive 
B cells exposed to membrane-bound HEL occurred com- 
parably in Ipr and normal mice, and concluded that defec- 
tive Fas expression did not interfere with central B cell 
tolerance induction. However, in studies with soluble HEL 
transgenic (Tg) mice, they found that the maintenance of 
peripheral tolerance in the Ipr anti-HEL mice was leakier 
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than in their non-lprcounterparts; a significant percentage 
of these older lpr double-transgenic animals developed 
elevated titers of serum anti-HEL antibody and had in- 
creased numbers of splenic anti-HEL antibody-forming 
cells (AFCs), indicating a breakdown in normal homeo- 
static control mechanisms. 
In another transgenic model of 6 cell tolerance, Erikson 
et al. (1991) found that in non-lpr mice transgenic for an 
anti-ssDNA 6 cell receptor, Vn3H9Nk8, the Tg+ B cells 
persisted but their immunoglobulin was not present in the 
serum. Recent studies have shown that these 6 cells are 
functionallycrippled(K.-A. N. andJ. E., unpublisheddata). 
Similarly, Roark et al. (1995) found that in non-lpr mice 
transgenic for the anti-DNA-associated VH3H9 IgH chain, 
B cells failed to produce detectable levels of antibodies 
with a homogeneous nuclear (HN) reactivity pattern; the 
corresponding MRL//pr Tg mice had elevated serum titers 
of both anti-DNA- and anti-HN-staining autoantibodies. 
HN-specific autoantibodies are prevalent in patients with 
systemic lupus erythematosus (Wallach, 1992). These re- 
sults further demonstrate that deficient Fas expression 
can result in defective regulation of autoreactive B cells. 
To understand better the role of the Ipr mutation in the 
breakdown of B cell tolerance and the production of auto- 
antibodies, it was important to determine when and where 
in the course of B cell differentiation defective Fas expres- 
sion could predispose an autoreactive B cell to actively 
produce autoantibodies. To address this issue, we investi- 
gated the anatomic localization of autoreactive B cells in 
the spleens of MRLllprmice, anticipating that their location 
might differ from that of antibody-secreting cells specific 
for conventional foreign antigens. It was reasoned that 
identification of the site where autoantibody producing 
cells accumulate might also elucidate how the lpr defect 
in B cells leads to autoantibody production and could iden- 
tify the critical point in B cell development where Fas ex- 
pression plays a role in maintaining tolerance. 
We used in situ hybridization and immunohistochemis- 
try to investigate the temporal and anatomic distribution 
of IgM- and IgG2a-producing B cells, as well as IgG2a- 
specific RF-producing cells, in splenic cryosections of Ipr 
and non-$rmice. Our results demonstrate that the inability 
to express Fas leads to an unusual and predominant local- 
ization of IgG2a AFC and anti-lgG2a RF-producing cells 
to the Tcell-rich inner PALS. This distribution pattern was 
not apparent in either young (10 weeks) or old (7 months) 
MRL/+ spleen, or in the non-lpr (SWR x NZB)Fi (SNFl) 
autoimmune strain. Moreover, in an autoreactive immuno- 
globulin transgenic system, B cells developing in an Ipr 
environment localized to the inner PALS, while B cells 
expressing the same receptor in a non-lpr environment 
did not. These results demonstrate that deficient Fas ex- 
pression can lead to the accumulation of B cells in the T 
cell-rich inner PALS. Continuous exposure to autoantigen 
and T cell help in this locale may result in the uncontrolled 
activation of B cells and subsequent dysregulated produc- 
tion of autoantibodies. 
Results 
The Cp and Cy2aJ Digoxigenin-Labeled Riboprobes 
Specifically Detect IgM- and 
IgG2a-Expressing Cells 
Prior to using the digoxigenin (DIG)-labeled IgM (Cp) and 
IgG2a (Cy2aJ) riboprobes on splenic tissue, we demon- 
strated their specificity on B cell hybridoma cytospin prep- 
arations. Figure 1 shows that the two antisense ribo- 
probes, Cu and Cu2aJ, strongly label cells making IgM 
and IgG2a mRNA, respectively, and that they do not cross- 
hybridize. The Cp probe specifically hybridized to an IgM- 
Cc1 Cy2aJ Figure 1. Specificity of Cn and Cy2aJ Anti- 
Sense Aiboprobes 
1 o-2 
W’4 
Cytospin preparations of MRUlpr RF-produc- 
ing hybridomas 10-2 (IgM) and I-2D (IgG2aJ) 
were hybridized with IgM and IgG2a antisense 
riboprobes. The Cl anti-sense DIG-labeled ri- 
boprobe hybridized to 10-2 cells (A) but not to 
l-2D cells (C). The Cy2aJ riboprobe did not hy 
bridize to 10-2 cells (6) but did bind to l-2D 
cells(D). The hybridized probes were detected 
with sheep anti-DIG-alkaline phosphatase and 
thesubstrates NBTand BCIP. Original magnifi- 
cation, 250 x 
I-2D 
(IgG2aJ) 
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secreting hybridoma, 1 O-2, but not to an IgG2asecreting 
hybridoma, l-2D, while the Cv2aJ probe exhibited the re- 
ciprocal specificity. The CCL and Cy2aJ riboprobes also 
failed to cross-react with IgGl-, IgG2b-, lgG3-, and IgA- 
producing cell lines (data not shown). Additionally, the 
Cy2aJ sense riboprobe did not hybridize to splenic tissue 
from MRLllpr mice positive for IgG2a-producing cells (data 
not shown). 
Anatomic Location of Resting 
and Activated B Cells 
When hybridized to splenic cryosections, the anti-sense 
C~.I riboprobe readily distinguished the lightly staining rest- 
ing slgM+ B cells from the more darkly staining AFC. The 
resting B cells in normal mice were mainly found in the 
outer PALS region of the white pulp, surrounding the CD4’ 
and CD8+ T cells present in the inner PALS (Figures 2A 
and 28). A similar distribution was found in young MRU 
Ipr mice. By comparison, the IgM AFCs in normal mice 
were localized predominantly in the red pulp, in many 
cases associated with the terminal arterioles, or with mar- 
ginal zone-bridging channels that traverse the marginal 
zones into the red pulp (Mitchell, 1973). IgM AFCs present 
in both young and old MRL/+ mice (1 l-32 weeks of age) 
showed a similar red pulp distribution (data not shown). 
Only rarely were IgM AFCs found in the inner PALS. 
While prediseased MRLllpr mice resembled the MRLI+ 
pattern, by 10-l 2 weeks of age, the IgM AFCs in the MRLl 
/or spleen exhibited a more heterogeneous distribution 
pattern. Many IgM AFCs were identified in the B cell outer 
PALS, in the red pulp, and along the terminal arterioles. 
Most significantly, unexpectedly high numbers of IgM 
AFCs were found in the T cell-rich inner PALS. Within a 
particular section, variation existed among the apparently 
anatomically distinct T cell regions in that certain PALS 
appeared to have a higher concentration of IgM AFCs than 
others (Figures 2D and 2E). 
IgG2a-Producing B Cells Exhibit a Predominant 
Localization to the Inner PALS 
in MRLllpr Spleen 
The Q2aJ probe detected very few resting B cells or AFCs 
in sections from normal BALBlc or MRL/+ spleen (Figure 
2C). As expected, those few IgG2a AFCs were located 
MRU+ MRLllpr 
17wks IOwkS 
MRL/tpr 
16tis 
Figure 2. In Situ Localization of IgM-, IgGPa-, and RF-Producing Cells in Young and Old pr and Normal Murine Splenic Tissue Sections 
IgM- and IgG2a-expressing cells were detected by in situ hybridization and T cells and RF-producing cells were identified by immunohistochemistry. 
Serial 6 urn splenic tissue sections were hybridized with either the anti-sense DIG-labeled riboprobes Cu (A, D, and G) or Cy2aJ (C, F, and I). and 
detected with sheep anti-DIG-alkaline phosphatase and NBTIBCIP. NBTlBClP produces a blue/black precipitate. Resting IgM’ cells exhibit a 
faint dark stain, whereas IgM- and IgG2a-producing cells appear more darkly stained. Sections were also double-stained with anti-CD4DIG, and 
anti-CDBDIG, and 23810 to identify T cells and RF-producing cells, respectively (B, E, and H). DIG-labeled antibodies were detected with sheep 
anti-DIG (gold) followed by silver enhancement, producing a brown precipitate. Localization of anti-lgG2a-binding RF B cells was demonstrated 
using the BIO-labeled reagent MAb 23 (IgGPa), followed by an avidin-biotin-alkaline phosphatase conjugate (ABC-AP) and the substrate Vector 
red. AP in the presence of Vector red produces a red precipitate. Arrows denote central arterioles in contiguous sections. Original magnification, 413~ 
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in the red pulp, often around the terminal arterioles. A 
dramatically different staining pattern was apparent in the 
lo- lPweek-old MRUlprspleens, where a dense accumu- 
lation of IgGPa AFCs was found interspersed with the sin- 
gle-positive (SP) T cells of the inner PALS, as identified 
by the staining of contiguous serial sections with CD4- and 
CDB-specific monoclonal antibodies (MAbs) (Figures 2E 
and 2F). Few IgG2a-producing cells were observed out- 
side of the PALS. The accumulation of these lgG2a AFCs 
correlated with the onset of elevated serum lgG2a titers 
(data not shown). The close association between IgG2a 
AFC and SP CD4+/CD8+ T cells was less apparent with 
disease progression in the older (>16 weeks) MRUlpr 
mice, as clusters of lgG2a AFCs appeared to shift from 
a predominant localization in the inner PALS to a more 
heterogeneous distribution pattern (Figures 2H and 21). 
Similarly, the IgM AFCs in the older MRL//pr became more 
heterogeneously dispersed (Figure 2G). 
IgG2a-Specific RF-Producing 6 Cells Also Localize 
to the Inner PALS in MRLllpr Mice 
The majority of MRUlpr mice develop extremely elevated 
anti-lgG2a RF titers, in part owing to extensive clonal 
expansions (Shlomchik et al., 1987). Therefore, the RF- 
secreting cells represent a prototypic autoantibody re- 
sponse. We developed an immunohistochemical staining 
technique that could specifically identify IgG2a-reactive 
RF-producing cells, using aggregated IgG2a as the detec- 
tion reagent. To avoid nonspecific reactivity with Fc recep- 
tors, staining was routinely carried out in the presence of 
4% normal rabbit serum (NRS). Under these conditions, 
the label reacted with RF-producing hybridoma cell lines, 
but not the SP2/0 fusion partner or the P388Dl macro- 
phage-like cell line that expresses high affinity FcyPa re- 
ceptors (Unkeless and Eisen, 1975) (data not shown). 
Using biotinylated lgG2a (MAb 23) in tandem with DIG- 
tagged anti-CD4 and antiCD8, we were able to demon- 
strate clearly that in lo- to 12-week-old MRU/pr sections, 
large numbers of RF AFCs were predominantly localized 
to the T cell-rich inner PALS (Figure 2E), similar to the 
pattern observed with the Cy2aJ probe. Although a few 
RF were found in the red pulp, the majority of RF- 
producing cells were restricted to the inner PALS. These 
sections demonstrate that autoantibody production in 
MRLllpr mice occurs outside the anatomical environment 
normally associated with AFC. By comparison, very few 
anti-lgG2a RF-producing cells were detectable in the 17- 
week-old MRU+ spleen, and those RF were mostly found 
in the red pulp (Figure 28). 
The striking PALS association of RF-producing cells 
seen in MRL/lpr mice early in disease also became more 
variable with disease progression (Figure 3D). By 16 
weeks, as the splenic architecture deteriorated, clusters 
of RF AFCs appeared to shift into the red pulp (Figure 
2H). At all timepoints, there was consistent colocalization 
of lgG2a AFCs and anti-lgG2a RF B cells in the MRLllpr 
sections. It should be noted, however, that RF-expressing 
cells were observed in other locations in MRLllpr spleen 
at lo-16 weeks: they were observed near the terminal 
arterioles in the red pulp, and as clumps of cells at the 
outer edge of the T cell zone, apposed to T cells. The 
clumps of RF-expressing cells at the interface of the outer 
and inner PALS are reminiscent of the foci described by 
Jacob et al. (1991a). 
Double-Negative T Cells Do Not Colocalize 
with AFC in /Pr Mice 
Double-negative (DN) Tcells accumulate in the peripheral 
lymphoid tissues of Ipr mice as disease progresses and 
are a major factor associated with the ensuing lymphoid 
hyperplasia (Morse et al., 1982; Theofilopoulos et al., 
1985). Although these cells are relatively refractory to stim- 
ulation (Davignon et al., 1985) they have been shown to 
have cytotoxic activity (Budd et al., 1986), to produce cyto- 
toxic molecules (Hammond et al., 1993) and even to se- 
crete a factor that putatively promotes the differentiation 
of resting B cells (Prud’homme et al., 1983). The DN T 
cells could be identified in splenic cryosections with a com- 
bination of MAbs specific for 8220 and mouse K light 
chain. Since both the DN T cells and B cells express 8220, 
but only the B cells express K light chain, the DN T cells 
appeared red and the B cells appeared brownish-red with 
this staining protocol. As expected, DN T cells could not 
be detected in MRL/+ spleen, and only B cells were evident 
in the regions surrounding the SP Tcells in the inner PALS 
(Figures 3A and 38). However, by lo-12 weeks of age, 
many DN T cells were detectable in the MRUlpr spleen. 
They were found in the B cell-rich outer PALS, sur- 
rounding CD4’ and CD8’ T cells in the inner PALS, and 
their numbers increased with disease progression. In the 
later stages of disease, DN T cells occupy most of the outer 
PALS, to the exclusion of resting slgM+ B cells (Figures 3C 
and 3D). At all times, the localization of the DN T cells to 
the resting B cell compartment of the outer PALS, also 
noted by Lieberum and Hartmann (1988) was clearly dis- 
tinct from the localization of AFCs in the T cell-rich inner 
PALS. The anatomic segregation of AFCs and DN T cells 
indicates that these T cells are probably not directly in- 
volved in B cell activation. 
Localization of IgM and lgG2a AFC in Other 
Autoimmune Strains 
It was important to determine whether the abnormal local- 
ization of IgM and IgG2a AFCs to the inner PALS in the 
MRUlprspleen was a general phenomenon characteristic 
of all autoantibody responses or whether it was unique to 
the Ipr mutation. Two approaches were taken to address 
this issue. First, we examined splenic sections from SNFl 
mice, another autoimmune strain known to develop high 
titers of lgG2a and autoantibodies. IgM and IgGPa AFCs 
were not found in the inner PALS of young (4 weeks) or 
older (25 weeks) SNFl mice (Figures 4A-4F), indicating 
that the inner PALS localization of AFCs seen in Ipr mice 
was not characteristic of all autoantibody-producing cells. 
IgG2a AFCs in the 25week-old SNFl mice were present 
in clusters in the outer PALS and dispersed throughout 
the red pulp. 
The second approach involved the examination of 
splenic sections from mice expressing an autoreactive 
transgenic B cell receptor. The transgenic receptor VH3H9/ 
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Figure 3. Accumulation of 8220+ DN T Cells in the Spleen, in the B Cell Region of the White Pulp 
Tissue sections from 17-week-old MRU+ (A) and MRUlpr (C) mice were stained with anti-k DIG and 8220610 to distinguish the 8220’ DN T cells 
from the 8220’ K+ S cells. The anti-k DIG was developed with sheep anti-DIG (gold), followed by silver enhancement, producing a brown precipitate. 
8220810 staining was followed by addition of avidin-biotin-alkaline phosphatase conjugate (ABC-AP) and the substrate Vector red. AP in the 
presence of Vector red produces a red precipitate. The double staining of resting S cells with anti-k DIG and 8220810 produced a brownish-red 
stain. Antibody-producing K+ cells do not express 8220 and therefore appear brown. DN T cells do not express K and therefore appear red, and 
are localized to the region between the inner PALS T cells and the marignal zone B cells. Serial sections of the MRU+ and MRUlpr spleen, 
respectively, were stained with reagents to identify T cells and RF-producing cells, as in Figure 2(B and D). A site of DN T cell accumulation is 
designated by an arrowhead, and a T cell-rich inner PALS is denoted with arrows in an MRL//pr spleen (C and D). Original magnification, 40x 
VK~ has been shown to bind ssDNA (Radic et al., 1991). 
Expression of this receptor in non-@ mice does not lead 
to detectable levels of circulating DNA-specific antibodies, 
although Tg+ B cells are known to constitute a major pro- 
portion of the splenic B cell population (Erikson et al., 
1991). Examination of sections from these non-@ Tg’ 
mice revealed a relatively normal distribution of resting 
slgM+ B cells or IgM+ AFC (Figures 5A and 5B). However, 
a direct comparison of Tg’ and Tg- sections suggested 
that a limited (but significantly different from control) num- 
ber of Tg+ cells were present in the inner PALS. 
A very different staining pattern was apparent in the 
VH3H9NK8Iprmice. Asshown in Figures5D andSE, stain- 
ing of contiguous sections with the CL riboprobe and anti- 
CD4 and anti-CD8 MAbs identified clusters of IgM AFCs 
in the T cell-rich inner PALS of 8-week-old Tg+ MRUlpr 
mice. Non-Tg Ipr littermates had typical clusters of inner 
PALS-associated IgG2a AFCs (Figure 51) that were not 
present in either the Tg+ BALBlc or Tg+ MRLllpr mice (Fig- 
ures 5C and 5F), presumably owing to constraints of the 
IgM construct. Altogether, these data strongly indicate that 
the association of autoreactive B cells with the inner PALS 
is unique to mice expressing defects in FaslFasL-medi- 
ated regulation. 
Discussion 
The Ipr mutation in MRL mice profoundly affects the regu- 
lation of both T and B lymphocytes, leading to the exces- 
sive production of autoantibodies. To understand better 
the role of FaslFasL-mediated apoptosis in the control of 
autoreactive B cells, we felt it was important to identify 
the specific localization of autoantibody-producing cells 
in Fas-deficient mice. Our observations indicate that the 
Ipr defect leads to a dramatic localization and accumula- 
tion of antibody-forming cells in the inner PALS of the 
spleen, a site from which they are normally excluded. 
For the purposes of this study, we chose to examine 
four types of B cells: resting slgM+ B cells, IgM-secreting 
B cells, IgG2asecreting B cells, and anti-lgG2a RF- 
secreting B cells. Resting slgM+ B cells are the dominant 
B cell population in normal lymphoid tissues, and their 
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4 wks 25 wks 
CCL 
Figure 4. Localization of IgGPa AFC in SNFl Mice 
Splenic cryosections from young (4 weeks) or old (25 weeks) SNFl mice were hybridized with either the anti-sense DIG-labeled riboprobes Cfr 
(A and D), or Cv2aJ (C and F) to detect IgM- and IgG2a-expressing cells, respectively, as described in Figure 2, or with anti-CD4DIG and anti-CDBDIG 
(6 and E). CD4’ and CDS’ SP T cells were visualized with sheep anti-DIG (gold) and silver enhancement. Arrows denote central arterioles in 
contiguous tissue sections. Original magnification, 132x. 
location provides an anatomic landmark by which to locate 
spatially the other responding cell types. In contrast, B 
cells actively secreting IgM are less prevalent in normal 
mice but have been associated with the early stages of 
/or disease (Klinman, 1990). The use of a Cu riboprobe 
to identify IgM+ B cells had a major advantage over the 
use of conventional anti-IgM antibody reagents in that it 
clearly distinguished resting IgM+ B cells from IgM AFCs 
on the basis of hybridization intensity. T cell areas sur- 
rounding the central arterioles could be clearly delineated 
by the absence of Cu riboprobe staining, and by the pres- 
ence of CD4’ and CD8+ T cells using the appropriate im- 
munohistochemical stains on contiguous serial tissue sec- 
tions. 
IgG2a-producing B cells were important to this analysis 
for several reasons. The appearance of high titers of lgG2a 
antibodies in the serum of diseased MRLllpr mice corre- 
lates with the progression of disease, and a major propor- 
tion of the disease-associated anti-nuclear autoantibodies 
are of this isotype (Slack et al., 1984; Rubin et al., 1986). 
Furthermore, lgG2a (as opposed to IgM) antibody expres- 
sion typically requires Tcell help, and we wanted to include 
potentially T cell-dependent (TD) autoantibodies in our 
analysis. A Cy2aJ r&probe was used to identify IgG2a- 
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BALBlc MRUlpr 
Tg Tg 
MRUlpr 
nonTg 
Figure 5. Distribution of IgM-Expressing Anti-DNA Transgenic B Cells in Normal and pr Spleens 
Splenic cryosections from Vn3H9NK8 Tg BALBlc, Tg MRUlpr, and non-Tg MRUlpr mice were hybridized with either the anti-sense DIG-labeled 
riboprobes Cu (A. D, and G), or Cv2aJ (C, F. and I), or anti-CD4DIG and anti-CDEDIG (B. E, and l-f) as described in Figure 2. Arrows denote central 
arterioles in contiguous tissue sections. Original ‘magnification, 132 x 
producing cells. In this case, the use of in situ hybridization 
was essential for identification of cells producing IgG2a; 
conventional anti-lgG2a immunohistochemistry, based on 
the use of IgG2aspecific antibodies, was not informative 
because it could not differentiate cells making the lgG2a 
from the IgG2a in the interstitial spaces or bound to cell 
surfaces. 
Anti-lgG2a RF-producing B cells were included as a pro- 
totypic autoantibody specificity. RF are a dominant com- 
ponent of the autoantibody pool of MRL/$r mice. Elevated 
RF titers are found in most MRUlpr mice, usually by 10 
weeks of age, and lo%-20% of the hybridoma cell lines 
isolated from diseased Ipr mice have been found to have 
RF activity (Wolfowicz et al., 1988). It is assumed that 
RF B cells receive T cell help as part of their maturation 
process, since they have been shown to undergo exten- 
sive clonal expansion and somatic mutation (Shlomchik 
et al., 1987). 
The DN T cell subset represents a major cell type in the 
peripheral lymphoid compartments of diseased /or mice. 
Our studies demonstrated that the DN T cells did not colo- 
calize with the AFC, consistent with recent in vitro studies 
showing that DN T cell populations rigorously depleted of 
SP T cells are functionally inert and incapable of providing 
B cell help (A. K. A. and A. M.-R., unpublished data). Their 
progressive accumulation in the white pulp of the spleen 
disrupts the anatomic organization and compartmental- 
ization of the various cell populations. The distortion of 
the splenic architecture likely affects the ability of both T 
cells and B cells to collaborate efficiently to mount a hu- 
moral response to a conventional foreign antigen. We 
monitored the kinetics of the accumulation of DN T cells 
relative to the time at which AFCs begin to localize to the 
inner PALS, to assess whether the AFC-PALS association 
was a secondary effect tied to disruption of the splenic 
architecture. This does not appear to be the case, as signif- 
icant accumulation of AFCs to the inner PALS was noted 
in mice with minimal numbers of DN T cells. Futhermore, 
Mountz et al. (1987) has shown that cyclosporin A treat- 
ment of MRUlpr mice inhibited the expansion of the DN 
T cells, yet did not affect serum autoantibody or immuno- 
globulin titers. This issue can be further evaluated in anti- 
CD8-treated (Giese and Davidson, 1994) or major histo- 
compatibility complex class I knockout /or mice (Mixter et 
al., 1995; Giese and Davidson, 1995) since these mice 
still make autoantibodies but do not develop DN T cells 
or lymphadenapathy. 
Recent studies have begun to elucidate the dynamics 
and anatomy of antigen-specific B cell activation and AFC 
formation, and it was important to examine the anatomic 
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localization of autoantibody production in the context of 
these reports. The anatomic site for antigen-specific B cell 
differentiation to antibody-producing cells has been identi- 
fied by the use of immunohistochemical techniques on 
splenic cryosections. B cells follow two distinct pathways 
of antigen-induced activation: an extrafollicular pathway 
of antibody secretion and heavy chain isotype switching, 
and an intrafollicular (germinal center) pathway of somatic 
hypermutation, affinity maturation, and memory cell gen- 
eration (McHeyzer-Williams et al., 1993). The first AFCs 
to develop during an immune response were observed by 
Van Ewijk et al. (1977) to occur at the border of the T and 
6 cell domains in the PALS. It appears that after a primary 
immunization with either TD or T cell-independent (TI) 
antigens, most antigen-specific AFCs are localized to the 
outer PALS and the sheaths of lymphoid tissue sur- 
rounding the terminal arterioles (Van Rooijen et al., 1986; 
MacLennan et al., 1990; Liu et al., 1991; Van Eertwegh 
et al., 1993). Additionally, Van Rooijen et al. (1988) found 
that AFCs that arose during a secondary response were 
found in the same anatomic sites within the spleen. Kelsoe 
and colleagues (Jacob et al., 1991 a) have further analyzed 
the anatomic location of the first AFCs to appear shortly 
after immunization. They showed that 2 days after immuni- 
zation of C57BU6 mice with a hapten-protein conjugate, 
low numbers of B cells making detectable amounts of hap- 
ten-specific antibody were located at the periphery of the 
PALS and around the terminal arterioles. By day 6 postan- 
tigen challenge, the antigen-specific AFCs had condensed 
to form foci, in apposition to T cells at the junction of the 
inner and outer PALS. Thus, according to our current un- 
derstanding, it appears that early in a primary response 
antigen-specific antibody-producing B cells arise at the 
interface of the inner and outer PALS and then can be 
seen migrating out of the white pulp along the marginal 
zone-bridging channels. Other sites of AFC localization 
have not previously been described. 
The surprising observation of inner PALS localization 
of IgGPa AFCs in MRL//pr mice contrasts dramatically with 
the observed localization of lgG2a AFCs to the outer 
PALS, red pulp, and the sheaths of the terminal arterioles 
in normal BALBlc and MRL/+ as well as autoimmune 
SNFl mice. We also found an @-associated dominant 
localization of cells secreting a prototypic autoantibody, 
anti-lgG2a RF, to the inner PALS of MRLllpr mice. Further- 
more, clusters of B cells expressing the VH3H9Nk8 Tg B 
cell receptor were also found in the inner PALS of 
transgene-expressing Ipr mice, although this accumula- 
tion was less striking than that observed in MRLllpr mice. 
We have not analyzed Ipr strains other than MRL, and 
have not studied lymph nodes or other tissues. However, 
the results with the immunoglobulin transgenic mice 
strongly supports the hypothesis that the abnormal accu- 
mulation of AFCs is associated with deficient Fas expres- 
sion. Two examples of autoreactive B cell accumulation 
in the inner PALS have been reported by Goodnow and 
colleagues. In the first study, Cyster et al. (1994) using 
the double-transgenic soluble HEUanti-HEL system, ob- 
served an accumulation of autoreactive B cells in the pe- 
riphery of the inner PALS. When they reconstituted a le- 
thally irradiated HEL Tg recipient with a mixture of 
anti-HEL Tg and normal non-Tg bone marrow cells, the 
anti-HEL autoreactive B cells were detained within the in- 
ner PALS, and thereby excluded from the microenviron- 
ment of mature recirculating B cells. The authors sug- 
gested that the detention and eventual death of the 
anti-HEL autoreactive B cells represented a unique path- 
way for the maintenance of tolerance. Thus, autoreactive 
anergic B cells, through a yet unknown mechanism, are 
unable to enter the B cell follicles and gain access to the 
mature recirculating pool of B lymphocytes. 
In the second study, Shokat and Goodnow (1995), again 
using the anti-HEL Tg B cell system, noted that a subset 
of Tg+ germinal center B cells that had been primed with 
duck egg lysozyme (DEL), for which their anti-HEL 
transgene has a lOOO-fold lower affinity, migrated to the 
periphery of the inner PALS within 4 hrof being immunized 
with soluble HEL. They also found increased apoptosis 
in the T cell zone 4 hr after soluble HEL administration; 
however, if the Tg+ B cells expressed a bcl-2 transgene 
the cells survived in the inner PALS. These two reports 
demonstrate the phenomenon of B cell accumulation to 
the inner PALS and show that they are eliminated there 
unless they receive the appropriate survival signals. In 
contrast, we have observed a dense accumulation of 
lgG2a B cells to the central zone of the inner PALS in the 
MRUlpr mouse. Not only do these B cells persist in the 
T cell zone, but they have been activated as indicated by 
their level of lgG2a mRNA. 
Anergic B cells, under normal circumstances, appear 
to be excellent targets for FasL-mediated cytotoxicity 
(Rathmell et al., 1995). Sensitivity to FasL presumably 
results from activation through CD40 by a CD40L- 
expressing T cell in the absence of an effective protective 
signal delivered through the antigen-specific slgM recep- 
tor (Rothstein et al., 1995). Since anergic Ipr B cells are 
defective in Fas expression, they cannot be eliminated 
appropriately by Fas-dependent mechanisms. We pro- 
pose that anergic autoreactive Ipr 6 cells that have been 
retained in the inner PALS can be activated by helper T 
cells expressing CD40L. Such autoreactive B cells nor- 
mally would be eliminated by means of the FasL coex- 
pressed by the same activated T cell population. However, 
Ipr B cells are resistant to such control signals, receive only 
positive signals from the neighboring activated T cells, 
and differentiate to autoantibody-secreting B cells. The 
architecture of the spleen, specifically the compartments 
of T cells in the inner PALS, recirculating IgM+ B cells in 
the outer PALS, as well as the trafficking pattern of the 
various cell populations, likely provides not only an essen- 
tial milieu for the efficient interaction of the appropriate 
cells for a humoral response (Van den Eertwegh et al., 
1992) but also an efficient mechanism for the mainte- 
nance of B cell tolerance. Immunization of normal mice 
with potent immunogens does not lead to accumulation 
of AFCs in the inner PALS. This is not surprising, because 
we would predict that in conventional immune responses 
Fas-FasL interactions would continue to play their regula- 
tory role. 
It will be important to characterize further the clonality 
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and specificities of the inner PALS-associated AFCs, 
given that this appears to be the region where tolerance 
is broken in the Fas-deficient animal. Previous work from 
this lab has shown that Ipr mice frequently exhibit clonal 
expansions of autoreactive B cells, particularly anti-DNA 
and RF. Additionally, these clones have been shown to 
undergo extensive somatic hypermutation. Together with 
the observations of the current report, these studies raise 
a number of provocative questions pertaining to the actual 
site of clonal expansion and somatic mutation in the Ipr 
and g/d models. Although numerous studies indicate the 
germinal centers are the major site of somatic mutation 
(Berek et al., 1991; Jacob et al., 1991b; McHeyzer- 
Williams et al., 1993) there is evidence that somatic muta- 
tion is not always restricted to the germinal centers (Chu 
et al., 1995). Since B cells in mice that inherit the @defect 
do not undergo Fas-mediated apoptosis, we propose that 
FaslFasL-associated mechanisms are responsible for the 
demise of autoreactive B cells that normally accumulate 
in the inner PALS; the persistence of these B cells in a 
milieu of autoreactive Tcells, as may occur in Fas-deficient 
mice, eventually results in expansion, activation, and ex- 
cessive autoantibody production. 
Experimental Procedures 
Animals 
MRL MpJ-+I+ and MRL MpJ-lprllpr mice were purchased from Jack- 
son Laboratory (Bar Harbor, Maine) and then maintained and bred at 
Boston University Medical Center Animal Care Facility under standard 
conditions. (SWR x NZB)Fl mice were provided by S. Datta (North- 
western University, Chicago, Illinois). The VH3H9NK6 Tg mice were 
bred and maintained in the core facility at the Wistar Institute. The 
heavy and light chain transgenes had been backcrossed for at least 
11 generations onto both BALE/c and MRL-/prNpr genetic back- 
grounds by breeding with parental strains obtained from the Jackson 
Laboratory. Progeny of transgenic breedings were genotyped by poly- 
merase chain reaction (PCR) amplification of tail DNA using transgene- 
specific primers, as described (Erikson et al., 1991). All V,3HS/VK8 Tg 
mice were maintained as hemizygotes under specific pathogen-free con- 
ditions. For this study, we analyzed eight MRUlpr homozygotes (625 
weeks old) and three MRU+ mice (6-30 weeks old), four anti-DNA 
immunoglobulin transgenics (2 +I+ and 2 Iprllpr). and two (SWR x 
NZB)Fl mice. 
Antibodies 
MAbs used in this study, rat anti-mouse K (RaM~)(33-18); anti-CD4 
(GK1.5); anti-CD8 (53-6.7); anti-B220 (682); IgGPa, I, anti-NIP (23). 
were either conjugated lo biotin (810) (Heitzman et al., 1974; Goding. 
1976) or digoxigenin (DIG), according lo the instructions of the manu- 
facturer (Boehringer Mannheim, Indiannapolis, Indiana), and used for 
immunohistochemistry. For detection of RF-producing B cells, 23810 
(lgh-lJ) was heat-aggregated immediately before use by diluting to 
500 vglml in phosphate-buffered saline (PBS) and heating at 63OC 
for 30 min (Jacobson 81 al., 1994). 
lmmunohistochemistry 
Murine spleens were snap-frozen in OCT (Tissue-Tek, Elkhart, Indi- 
ana) by submersing in P-methylbutane cooled by liquid nitrogen for 
4-5 s. Longitudinal sections 6 pm thick were thaw mounted onto Bio- 
bond (Biocell, Cardiff) coated glass slides, quickly fixed by dipping in 
ice-cold acetone for 4-5 s. and stored at -20°C until ready lo use. For 
all immunohistochemical staining, previously cut cryosections were 
transferred quickly to ice-cold acetone, fixed for 3 min, washed three 
times for 5 min in PBS, and preinct$ated with 4% NRS. Biotin-labeled 
antibody solutions containing 4% NRS were added to the sections 
and incubated for 60 min in a humidified chamber. The biotin-stained 
slides were washed three times in PBS, incubated for 60 min with an 
avidin-biotin-alkaline phosphatase conjugate (ABC-AP, Vector Labs, 
Burlingame, California), washed again as above, and incubated with 
Vector red substrate solution (Vector Labs) containing 1 mM levami- 
sole. All tissues stained with DIG-labeled antibodies were preincu- 
bated as above with 4% NRS, followed by incubation with the DIG- 
labeled antibodies for 60 min. The sections were then washed three 
times in PBS and incubated with 5% nonfat dry milk in PBS containing 
4% NRS. washed again, and incubated with 100 PI sheep anti-DIG 
gold (5 nm) (Goldmark Biologicals, Phillipsburg, New Jersey) diluted 
1:lOO in PBS, 4% NRS for 60 min. The slides were then washed three 
times in 0.05 M sodium citrate, and 100 pl of silver enhancement 
solution added (Biocell). The gold bound to the tissue reduced the 
silver in solution and a brown/black deposit developed. For double- 
staining with BIO- and DIG-coupled antibodies, tissue sections were 
blocked as above, and then both primary antibodieswere added simul- 
taneously. When sections were stained with 23810, the incubation 
was done overnight a1 4OC. After incubation with the primary reagents, 
the sections were rinsed three times in PBS and incubated with 5% 
nonfat dry milk containing 4% NRS, rinsed in PBS, and incubated 
with a 1:lOO dilution of sheep-anti-DIG gold (5 nm) for 60 min. After the 
sheep-anti-DIG gold (5 nm) was removed, the sections were incubated 
with ABC-AP for another 60 min, washed three times in 50 mM sodium 
citrate, and then incubated with silver enhancement solution until ade- 
quate color development. The sections were rinsed twice in 50 mM 
sodium citrate, followed by a rinse in PBS. They were then incubated 
with the Vector red substrate solution. 
Riboprobes 
Two RNA probes were used for in situ hybridization, C&I, and Cy2aJ. 
The Cp probe was provided by R. P. Bucy (University of Alabama, 
Birmingham, Alabama). The Cv plasmid contained an 800 bp EcoRI- 
Hindlll fragment from the mouse heavy chain IgM constant region. 
The fragment included bases283-1084. Theconstant region fragment 
contained a BamHl site at nucleotide postition 578 downstream of 
the SP6 RNA polymerase transcription start site. The plasmid was 
linearized with BamHl and transcribed with SP6 RNA polymerase and 
deoxynucleotides containing dUTP-DIG (according lo the manufac- 
turer, Boehringer-Mannheim), to give DIG-labeled anti-sense tran- 
scripts of approximately 570 bases. DIG-labeled sense transcripts of 
approximately 800 bases were produced by linearizing C+ with Hindlll 
and transcribing with T7 RNA polymerase. The Cy2aJ probe was con- 
structed in this laboratory. The Cy2aJ insert was derived from PCR- 
amplified DNA from the CH3 region (base pairs 1053-1325) of hybrid- 
oma 23 cDNA. The insert was cloned into pGEM1. Anti-sense 
DIG-labeled IgGPa transcripts of approximately 280 bases were pro- 
duced by linearizing the plasmid with EcoRl and transcribing with SP6 
RNA polymerase. DIG-labeled sense transcripts of 280 bases were 
produced by linearizing the plasmid with Hindlll and transcribing with 
T7 RNA polymerase. DIG-labeled riboprobes were produced ac- 
cording to theinstructionsofthemanufacturer(Boehringer-Mannheim, 
Indiannapolis, Indiana). 
In Situ Hybridization 
Tissue sections 6 vrn thick were cu1 in a cryostat with an RNase-free 
cryostat blade and thaw mounted onto cleaned and baked RNase-free 
glass slides. The sections were air dried for 1 O-20 min at room temper- 
ature, and then fixed in 3% paraformaldehyde in PBS for 1 hr. The 
slides were rinsed in 0.1 M triethanolamine (Sigma) (pH 8.0) for 5 
min, and then the tissue was acetylated by incubation in 0.1 M tri- 
ethanolamine. with 0.25% acetic anhydride (Sigma), for 15 min, and 
rinsed again in 0.1 M triethanolamine. The sections were incubated 
with prehybridization solution (50% formamide, 4x SSC, 250 pg/ml 
of yeast 1RNA, 0.4 x Denhardt’s, 10% dextran sulfate, and 500 pg/ 
ml salmon testes DNA; the DNA was heated lo 65OC for 10 min prior 
lo use) for 1 hr. DIG-labeled riboprobe (10 ~1) (denatured by heating 
to80°C for5 min)wasadded tothe undersideof asiliconizedcoverslip, 
applied to the section, sealed with nail polish, and hybridized at 52OC 
for 15-18 hr. Typically, 2-20 ng of Cp probe and l-2 ng of Cv2aJ 
probe were used per slide. Following hybridization, the coverslips were 
removed and the slides rinsed three times in 2 x SSC, followed by a 
rinse in STE (500 mM NaCI. 1 mM EDTA [pH 8.01, 20 mM Tris-HCI 
[pH 7.5]), and then incubated with RNase A (50 pglml) in STE at 37OC 
for 45 min. The slides were then incubated in 50% formamide, 2 x 
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SSC at 53% for 20 min, rinsed one time in 1 x SSC, rinsed three 
times in 0.5 x SSC, and finally rinsed one time in buffer #l (100 mM 
Tris-Cl [pH 7.51, 150 mM NaCI). The tissue was preincubated in 2% 
NRS in buffer#l for20 min, and then incubated with sheep anti-DIG-AP 
F(ab), (Catalog number 1093-274, Boehringer-Mannheim) diluted 1: 
500 in buffer #l, for 1 hr. The slides were rinsed one time in buffer 
#l. followed by a 10 min rinse in buffer #2 (100 mM Tris-Cl, 100 mM 
NaCI, 50 mM MgCI? [pH 9.51). Lastly, the substrate solution containing 
450 uglml of nitro blue tetrazolium salt, B-M, and 175 uglml of 5-bromo- 
4-chloro+indolyl phosphate toludium salt, B-M, and 1.25 mM levami- 
sole (Vector Labs) in buffer #2 was added to the tissue, and incubated 
for 24-46 hr in the dark at 4%. After sufficient substrate development, 
the slides were washed extensively in Tris-EDTA (10 mM Tris-HCI 
[pH 6.0]. 1 mM EDTA (pH 6.01) and mounted with Aquamount (Lerner 
Laboratories, Pittsburgh, Pennsylvania). 
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